Clinical News
Informatics
Industry News
Medical, Legal, And Practice
Education
Subspecialties
More
Sign In
Breast Imaging
CV
Chest
Emergency
GI
GU
Head & Neck
Interventional
Physics
MSK
Neuro
Nuclear
Pediatric
Radiation Oncology
Genitourinary Radiology: Page 18
Radiopharmaceutical targets bone metastases in prostate cancer
By
Cynthia E. Keen
An experimental drug that delivers small doses of radiation to bone metastases in prostate cancer patients has shown that it can prolong survival significantly, according to research presented at the European Multidisciplinary Cancer Congress, held in Stockholm this week.
September 27, 2011
Elastography beats ultrasound in prostate cancer detection
By
Reuters Health
NEW YORK (Reuters Health) - Compared with conventional grayscale ultrasonography, transrectal real-time elastography improves the detection of prostate cancer -- but it's not ready for prime time yet, German researchers say.
August 21, 2011
BK Medical launches device for prostate imaging
By
AuntMinnieEurope.com staff writers
Analogic subsidiary BK Medical has introduced a robotic ultrasound device for prostate imaging.
March 23, 2011
Consensus grows for switch from fluoroscopy to MRI in pelvic floor imaging
By
Edna Astbury-Ward
After years of using conventional fluoroscopic evacuation proctography, radiologists at London's University College Hospital have switched entirely to MR proctography for imaging the pelvic floor. The clinical rational behind the change was the focus of a European Congress of Radiology session Friday.
March 3, 2011
USHIFU adds Brazilian, Russian customers
By
AuntMinnieEurope.com staff writers
High-intensity focused ultrasound (HIFU) developer USHIFU announced that its Sonablate 500 medical device is now available for the first time for prostate cancer patients living in Brazil, at the Hospital Nossa Senhora das Graças in Curitiba.
February 16, 2011
Radiation plus gemcitabine might be as good as surgery for bladder cancer
By
Reuters Health
NEW YORK (Reuters Health) - Radiation plus gemcitabine may be as good as cystectomy for muscle-invasive bladder cancer, a phase II study suggests. Results were reported online January 4 in the
Journal of Clinical Oncology
.
January 12, 2011
Brachytherapy good option for younger prostate cancer patients
By
Reuters Health
NEW YORK (Reuters Health) - Brachytherapy is a viable option for prostate cancer patients 60 years and younger, researchers from University Medical Center Utrecht in the Netherlands conclude in a new report in
BJU International
.
December 8, 2010
EDAP products registered in France
By
AuntMinnieEurope.com staff writers
EDAP TMS has announced that its Sonolith lithotripter products, including Sonolith i-sys and Sonolith i-move, have been exclusively registered by UGAP, the French Public Purchasing Agency.
December 6, 2010
Chemo + radiation may save cancerous bladders
By
Reuters Health
NEW YORK (Reuters Health) - Treatment with chemotherapy plus radiation therapy is a viable alternative to radical surgery in some patients with muscle invasive bladder cancer, according to presentation at Monday's plenary session of the American Society for Radiation Oncology annual meeting.
November 3, 2010
Pre-op RT improves rectal cancer outcomes
By
Reuters Health
NEW YORK (Reuters Health) - A short course of radiation therapy (RT) prior to total mesorectal excision for rectal cancer cuts the long-term risk of recurrence in half, according to data presented at this week's American Society for Radiation Oncology (ASTRO) meeting in San Diego.
November 2, 2010
High-intensity focused US for prostate cancer: no good evidence
By
Reuters Health
NEW YORK (Reuters Health) - There is no good evidence to support the use of high-intensity focused ultrasound in prostate cancer, although the treatment was developed nearly two decades ago.
October 28, 2010
Low-risk prostate cancer patients choose surveillance in U.K.
By
Cynthia E. Keen
Thousands of men in the U.K. diagnosed with low-risk localized prostate cancer are delaying aggressive treatment, according to a new study in the October issue of
BJU International
. Instead, they are opting for active surveillance that includes monitoring and testing of prostate-specific antigen levels.
October 20, 2010
Previous Page
Page 18 of 22
Next Page